StreetAlpha.app
Home › Stocks › AXGN

Axogen, Inc. (AXGN)

Healthcare
$55.75
▼ −1.06%
LAST CLOSE · NOV 20

Axogen makes products for peripheral nerve repair, sold to surgeons and other healthcare providers. It last closed at $55.75 on Nov 20, down 1.06% on the day. The next earnings report for AXGN is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, AXGN reported EPS of $0.04 on revenue of $75.8M, with revenue up 26.2% from a year ago. Over its last 8 reports the stock moved an average of 13.5% the session after earnings. Over the last 12 months AXGN insiders bought $0 of stock on the open market and sold $17.1M, according to SEC Form 4 filings.

AI Auto Pilots
Is AXGN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold AXGN.

Key Stats

Last 12 months
Results
Revenue
$266.9M
+24.3% vs a year ago
Net income
−$31.9M
−12.0% margin
EPS (diluted)
−$0.63
Free cash flow
$22.0M
8.3% margin
Valuation
Market cap
$3.3B
59.7M shares
P/E
–
No P/E while losing money
Price to sales
12.5
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$328.9M
At Sep 30
Debt
$0
At Sep 30
Shareholder equity
$496.1M
Shares outstanding
59.7M
At Oct 26
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $127.4M$127.4MFY2021FY2022: $138.6M$138.6MFY2022FY2023: $159.0M$159.0MFY2023FY2024: $187.3M$187.3MFY2024FY2025: $225.2M$225.2MFY2025

From AXGN's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 28). Last 12 months adds up the four latest quarters.

Next report
Jan 11
Estimated date · Time not announced
Reported EPS
$0.04
Quarter ended Sep 2026
Year ago EPS
$0.01
+300.0% on a GAAP basis
Revenue
$75.8M
+26.2% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.01Dec '24Mar 2025: -$0.08Mar '25Jun 2025: $0.01Jun '25Sep 2025: $0.01Sep '25Dec 2025: -$0.28Dec '25Mar 2026: -$0.38Mar '26Jun 2026: -$0.03Jun '26Sep 2026: $0.04Sep '26Latest $0.04
Revenue by quarter
Dec 2024: $49.4MDec '24Mar 2025: $48.6MMar '25Jun 2025: $56.7MJun '25Sep 2025: $60.1MSep '25Dec 2025: $59.9MDec '25Mar 2026: $61.5MMar '26Jun 2026: $69.7MJun '26Sep 2026: $75.8MSep '26Latest $75.8M
How AXGN moved after its last 8 reports
Average move the session after a report ±13.5%
Oct 28, 2026Time not announced+31.5%
Jul 29, 2026Time not announced+0.5%
Apr 28, 2026Time not announced+6.6%
Feb 24, 2026Time not announced−8.1%
Jan 12, 2026Time not announced−5.8%
Oct 29, 2025Time not announced+23.1%
Aug 5, 2025Time not announced+9.3%
May 8, 2025Time not announced−23.2%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on AXGNStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on AXGN
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on AXGN

Technical Analysis

AXGN · as of the Nov 20 close · updated each morning
Uptrend, nearing overbought

The stock is 8% above its 20 day and 20% above its 50 day average. It is 26% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 66), near overbought. The nearest support is the Pivot S1 at $54.88, and the nearest resistance the Pivot at $55.90.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityHigh, 4.8%/day
Key levels
$59.7252 week high+7.1%
$59.72Swing high (Nov 11)+7.1%
$56.76Pivot R1+1.8%
$55.90Pivot+0.3%
$55.75Last close
$54.88Pivot S1−1.6%
$51.2220 day average−8.1%
$47.57Swing low (Nov 5)−14.7%
$44.75100 day average−19.7%
$44.3450 day average−20.5%
$41.06200 day average−26.3%
$25.1652 week low−54.9%
Indicators
RSI (14)66.41Strong, overbought above 70Neutral
MACD3.92Above its signal lineBullish
Stochastic72.3Middle of its rangeNeutral
ADX (14)48.2Strong uptrend
Williams %R-32.7Oversold below −80, overbought above −20Neutral
CCI (20)79.3Oversold below −100, overbought above 100Neutral
Rate of change+11.5%Change over 10 sessionsBullish
ATR (14)$2.70Typical daily range, 4.8% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for AXGN

What happened before

See how AXGN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow AXGN usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How AXGN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2013.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for AXGNHow many large options trades hit AXGN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

AXGN Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ●135 buying vs 122 selling
  • ▲Held by funds +9.3 pts
  • ●Funds holding -2
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding253255−0.8%
In funds' top 1056−16.7%
Held by funds99.8%90.5%+9.3 pts
New / increased36 / 9950 / 111−16.1%
Reduced / sold out82 / 4064 / 19+47.0%
Put/call ratio0.00––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See AXGN institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AXGN Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$17.1M24 sales · 11 insiders
27% of the selling was under pre-arranged trading plans.
2025-12 sold $10.6M2026-03 sold $171K2026-05 sold $1.7M2026-08 sold $4.5M2026-09 sold $174KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Sep 2Joseph A. TyndallDirectorSale plan3,500$49.70$174K
Aug 11Amy McBride WendellDirectorSale plan13,353$48.42$647K
Aug 10Marc A BeganEVP & General CounselSale plan67,500$47.34$3.2M
Aug 7Kathy Johnson WeilerDirectorSale plan14,150$45.30$641K
May 8Amy McBride WendellDirectorSale1,647$42.60$70K
May 7Doris QuackenbushSales VPSale3,878$43.51$169K
Every insider buy and sale for AXGN over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See AXGN insider trades →

From SEC Form 4 filings by AXGN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AXGN is in one of them and how their past AXGN trades turned out.

AXGN in the AI portfolios
Loading…

AXGN News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered AXGN in an article yet. Here's the latest on the wider market.

AXGN in the news

AXGN Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Apr 27
Who traded AXGN · since 2019
Latest 2 filings
$1K – $15KTraded Jun 24, 2019Filed Apr 27, 2020
$1K – $15KTraded Apr 16, 2019Filed Apr 27, 2020
PersonTypeAmountTradedFiledDelay
Donna ShalalaD · FLSell$1K – $15KJun 24, 2019Apr 27, 2020308 d
Donna ShalalaD · FLBuy$1K – $15KApr 16, 2019Apr 27, 2020377 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Axogen

Axogen is based in Alachua, Florida, and develops and sells products for repairing peripheral nerves, the pathways that carry movement and sensation signals throughout the body. Its main offerings include nerve grafts for bridging severed nerves, nerve connectors and protectors made from pig tissue, and a soft tissue matrix made from amniotic membrane. Surgeons and other healthcare providers use these products in surgeries to treat traumatic injuries, dental and orthopedic procedures, and breast reconstruction. Its products are sold mainly in the United States, with sales also in Canada, Germany, the United Kingdom, Spain and several other countries.

Headquarters
Alachua, FL